Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus
Neera R. Nathan(National Heart Lung and Blood Institute), Thomas N. Darling(Uniformed Services University of the Health Sciences), Jianwu Wang(Zhejiang Business Technology Institute), Edward W. Cowen(National Institutes of Health), Mary Haughey(National Heart Lung and Blood Institute), Joel Moss(National Heart Lung and Blood Institute), Shaowei Li(Uniformed Services University of the Health Sciences)
Cited by 52
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
|Journal of Clinical Investigation|2018|519